It is in accordance with studies by Hofmann et al. (73) who demonstrated that TRPV1 is involved in the uptake of anandamide, the endogenous cannabinoid and agonist of TRPV1 implicated in tumor-angiogenesis, by human endothelial colony-forming cells (ECFCs), and a human endothelial-vein cell line (E.A.hy926). Here, TRPV1 is linked to neoplasm.